PMID- 37808894 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231031 IS - 2328-8957 (Print) IS - 2328-8957 (Electronic) IS - 2328-8957 (Linking) VI - 10 IP - 10 DP - 2023 Oct TI - Safety of Single High-Dose Liposomal Amphotericin B for Induction Treatment of Cryptococcal Meningitis and Histoplasmosis in People With HIV: A Systematic Review and Meta-analysis. PG - ofad472 LID - 10.1093/ofid/ofad472 [doi] LID - ofad472 AB - BACKGROUND: Evidence for efficacy of single, high-dose liposomal amphotericin B (LAmB) in HIV-associated cryptococcal meningitis and histoplasmosis is growing. No systematic review has examined the safety of this regimen across multiple studies. METHODS: We systematically searched Medline, Scopus, and the Cochrane Library from inception to April 2023 for studies reporting grade 3 and 4 adverse events (AEs) with single high-dose LAmB vs traditional amphotericin regimens for HIV-associated fungal infections. RESULTS: Three trials (n = 946) were included. Compared with traditional regimens, single high-dose LAmB was associated with equivalent risk of grade 3 and 4 AEs (risk ratio [RR], 0.75; 95% CI, 0.53-1.06) and lower overall risk of grade 4 AEs (RR, 0.68; 95% CI, 0.55-0.86), grade 4 renal (RR, 0.43; 95% CI, 0.20-0.94) and grade 4 hematological AEs (RR, 0.46; 95% CI, 0.32-0.65). CONCLUSIONS: Single, high-dose LAmB is associated with a lower risk of life-threatening AEs compared with other World Health Organization-endorsed amphotericin B-based regimens in invasive HIV-related fungal infection. CI - (c) The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. FAU - Kang, HeeEun AU - Kang H AUID- ORCID: 0009-0000-9794-9666 AD - Infectious Disease and International Health, Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA. AD - Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. FAU - Uy, John P AU - Uy JP AD - Infectious Disease and International Health, Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA. AD - Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. FAU - Ho, Caroline C AU - Ho CC AD - Infectious Disease and International Health, Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA. AD - Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. FAU - Blunt, Heather B AU - Blunt HB AD - Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. FAU - Riblet, Natalie B AU - Riblet NB AD - Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. FAU - Pasqualotto, Alessandro C AU - Pasqualotto AC AD - Infectious Diseases, Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, Brazil. FAU - Murphy, Richard A AU - Murphy RA AD - Infectious Disease and International Health, Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA. AD - Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. AD - White River Junction VA Medical Center, Hartford, Vermont, USA. LA - eng PT - Journal Article PT - Review DEP - 20230920 PL - United States TA - Open Forum Infect Dis JT - Open forum infectious diseases JID - 101637045 PMC - PMC10551850 OTO - NOTNLM OT - HIV infection OT - antifungal OT - cryptococcal meningitis OT - histoplasmosis OT - opportunistic infections COIS- Potential conflicts of interest. All authors: no reported conflicts. EDAT- 2023/10/09 06:41 MHDA- 2023/10/09 06:42 PMCR- 2023/09/20 CRDT- 2023/10/09 05:47 PHST- 2023/07/24 00:00 [received] PHST- 2023/09/13 00:00 [accepted] PHST- 2023/10/09 06:42 [medline] PHST- 2023/10/09 06:41 [pubmed] PHST- 2023/10/09 05:47 [entrez] PHST- 2023/09/20 00:00 [pmc-release] AID - ofad472 [pii] AID - 10.1093/ofid/ofad472 [doi] PST - epublish SO - Open Forum Infect Dis. 2023 Sep 20;10(10):ofad472. doi: 10.1093/ofid/ofad472. eCollection 2023 Oct.